Bone or cartilage mass screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Mahshid) |
||
Line 12: | Line 12: | ||
{{Reflist|1}} | {{Reflist|1}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Rheumatology]] | |||
[[Category:Orthopedics]] |
Latest revision as of 02:32, 6 November 2017
Bone or Cartilage Mass Microchapters |
Diagnosis |
---|
Case Studies |
Bone or cartilage mass screening On the Web |
American Roentgen Ray Society Images of Bone or cartilage mass screening |
Risk calculators and risk factors for Bone or cartilage mass screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
According to the the National Cancer Institute (NCI) there is insufficient evidence to recommend routine screening for bone or cartilage tumors.[1]
Screening
According to the the National Cancer Institute (NCI) there is insufficient evidence to recommend routine screening for bone or cartilage tumors.[1]
References
- ↑ 1.0 1.1 Bone Cancer—Health Professional Version (2016) http://www.cancer.gov/types/bone/hp Accessed on February, 8th 2016